Gliomatosis cerebri epidemiology and demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Gliomatosis cerebri is a rare brain tumor. The incidence of gliomatosis cerebri is estimated to be less than 100 cases per year in the United States. Gliomatosis cerebri is a disease that tends to affect the middle-aged population. The peak incidence for gliomatosis cerebri is 20-40 years. The median age at diagnosis is 34 years. Males are more commonly affected with gliomatosis cerebri than females. The male to female ratio is approximately 1.5 to 1.
Epidemiology and Demographics
Incidence
- Gliomatosis cerebri is a rare brain tumor. The incidence of gliomatosis cerebri is estimated to be less than 100 cases per year in the United States.[1]
Age
- Gliomatosis cerebri is a disease that tends to affect the middle-aged population. The peak incidence for gliomatosis cerebri is 20-40 years.[2]
- The median age at diagnosis is 34 years.[3]
Gender
- Males are slightly more affected than females. The male to female ratio is approximately 1.5 to 1.[2]
Incidence
- The annual incidence rate of gliomatosis cerebri is approximately 0.1 per 1,000,000 individuals worldwide.[4]
Race
- There is no data on racial predilection for gliomatosis cerebri.
Region
- There is no data on regional and geographical predilection for gliomatosis cerebri.
Developed Countries
Developing Countries
References
- ↑ Gliomatosis cerebri international registry. http://gcregistry.com/
- ↑ 2.0 2.1 Epidemiology of gliomatosis cerebri. Dr Henry Knipe and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/gliomatosis-cerebri
- ↑ Kim DG, Yang HJ, Park IA, Chi JG, Jung HW, Han DH; et al. (1998). “Gliomatosis cerebri: clinical features, treatment, and prognosis”. Acta Neurochir (Wien). 140 (8): 755–62. PMID 9810441.
- ↑ “Incidence and survival of gliomatosis cerebri: a population-based cancer registration study”.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH